Case Reports
doi: 10.1136/bcr.08.2011.4674.
Chronic inflammatory demyelinating polyradiculoneuropathy complicating anti TNF α therapy for chronic plaque psoriasis
Affiliations
- PMID: 22674940
- PMCID: PMC3229329
- DOI: 10.1136/bcr.08.2011.4674
Item in Clipboard
Case Reports
Chronic inflammatory demyelinating polyradiculoneuropathy complicating anti TNF α therapy for chronic plaque psoriasis
BMJ Case Rep.
.
Abstract
A 53-year-old woman with chronic plaque psoriasis treated with adalimumab (antitumour necrosis factor (anti TNF) α therapy) for 10 months presented with an 8 week history of hyperesthesia in a 'glove and stocking' distribution and clumsiness on walking. Nerve conduction studies confirmed the clinical diagnosis of a chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). She was admitted and treated with intravenous immunoglobulin and oral steroids and made an excellent recovery. To our knowledge, this is the first published report of CIDP associated with anti TNF α therapy given to treat psoriasis.
Conflict of interest statement
Similar articles
-
Chronic inflammatory demyelinating polyneuropathy and psoriasis comorbidity with significantly alleviated in symptoms after secukinumab: case report.BMC Neurol. 2022 Nov 2;22(1):400. doi: 10.1186/s12883-022-02928-3. BMC Neurol. 2022. PMID: 36324078 Free PMC article.
-
Bilateral facial nerve palsies secondary to chronic inflammatory demyelinating polyneuropathy following adalimumab treatment.Clin Neurol Neurosurg. 2018 Jan;164:64-66. doi: 10.1016/j.clineuro.2017.11.001. Epub 2017 Nov 22. Clin Neurol Neurosurg. 2018. PMID: 29179036
-
Development of sarcoidosis during adalimumab therapy for chronic plaque psoriasis.Australas J Dermatol. 2011 Aug;52(3):e8-11. doi: 10.1111/j.1440-0960.2010.00660.x. Epub 2010 Jun 23. Australas J Dermatol. 2011. PMID: 21834808
-
Anti-TNF agents for the treatment of psoriasis.J Drugs Dermatol. 2009 Jun;8(6):546-59. J Drugs Dermatol. 2009. PMID: 19537380 Review.
-
Development of chronic cutaneous lupus erythematosus during biologic therapy: A systematic review.J Am Acad Dermatol. 2021 Mar;84(3):835-838. doi: 10.1016/j.jaad.2020.09.087. Epub 2020 Oct 3. J Am Acad Dermatol. 2021. PMID: 33022308 No abstract available.
Cited by
-
Non-length-dependent and length-dependent small-fiber neuropathies associated with tumor necrosis factor (TNF)-inhibitor therapy in patients with rheumatoid arthritis: expanding the spectrum of neurological disease associated with TNF-inhibitors.Semin Arthritis Rheum. 2014 Apr;43(5):638-47. doi: 10.1016/j.semarthrit.2013.10.007. Epub 2013 Oct 30. Semin Arthritis Rheum. 2014. PMID: 24439654 Free PMC article.
-
Immunomodulatory treatment other than corticosteroids, immunoglobulin and plasma exchange for chronic inflammatory demyelinating polyradiculoneuropathy.Cochrane Database Syst Rev. 2017 May 8;5(5):CD003280. doi: 10.1002/14651858.CD003280.pub5. Cochrane Database Syst Rev. 2017. PMID: 28481421 Free PMC article.
-
Guillain-Barré syndrome in association with antitumour necrosis factor therapy: a case of mistaken identity.BMJ Case Rep. 2017 Jul 5;2017:bcr2017219481. doi: 10.1136/bcr-2017-219481. BMJ Case Rep. 2017. PMID: 28679512 Free PMC article.
-
Chronic inflammatory demyelinating polyneuropathy and psoriasis comorbidity with significantly alleviated in symptoms after secukinumab: case report.BMC Neurol. 2022 Nov 2;22(1):400. doi: 10.1186/s12883-022-02928-3. BMC Neurol. 2022. PMID: 36324078 Free PMC article.
-
Neurological Complications of Therapeutic Monoclonal Antibodies: Trends from Oncology to Rheumatology.Curr Neurol Neurosci Rep. 2017 Aug 17;17(10):75. doi: 10.1007/s11910-017-0785-3. Curr Neurol Neurosci Rep. 2017. PMID: 28819716 Review.
References
-
- Lozeron P, Denier C, Lacroix C, et al. Long-term course of demyelinating neuropathies occurring during tumor necrosis factor-alpha-blocker therapy. Arch Neurol 2009;66:490–7 - PubMed
-
- Magnano MD, Robinson WH, Genovese MC. Demyelination and inhibition of tumor necrosis factor (TNF). Clin Exp Rheumatol 2004;22(5 Suppl 35):S134–40 - PubMed
-
- Robinson WH, Genovese MC, Moreland LW. Demyelinating and neurologic events reported in association with tumor necrosis factor alpha antagonism: by what mechanisms could tumor necrosis factor alpha antagonists improve rheumatoid arthritis but exacerbate multiple sclerosis? Arthritis Rheum 2001;44:1977–83 - PubMed
-
- Alshekhlee A, Basiri K, Miles JD, et al. Chronic inflammatory demyelinating polyneuropathy associated with tumor necrosis factor-alpha antagonists. Muscle Nerve 2010;41:723–7 - PubMed
-
- Das A, Kalita J, Misra UK. Recurrent Guillain Barre’ syndrome. Electromyogr Clin Neurophysiol 2004;44:95–102 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
